Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Mar 18;16(3):e0241729. doi: 10.1371/journal.pone.0241729

Silver nanoparticles from insect wing extract: Biosynthesis and evaluation for antioxidant and antimicrobial potential

Parameshwar Jakinala 1,#, Nageshwar Lingampally 1,#, Bee Hameeda 1,*,#, R Z Sayyed 2,, Yahya Khan M 3,, Elsayed Ahmed Elsayed 4,5,, Hesham El Enshasy 6,7,
Editor: Pradeep Kumar8
PMCID: PMC7971846  PMID: 33735177

Abstract

Silver nanoparticles (AgNPs) are among the most widely synthesized and used nanoparticles (NPs). AgNPs have been traditionally synthesized from plant extracts, cobwebs, microorganisms, etc. However, their synthesis from wing extracts of common insect; Mang mao which is abundantly available in most of the Asian countries has not been explored yet. We report the synthesis of AgNPs from M. mao wings extract and its antioxidant and antimicrobial activity. The synthesized AgNPs were spherical, 40–60 nm in size and revealed strong absorption plasmon band around at 430 nm. Highly crystalline nature of these particles as determined by Energy-dispersive X-ray analysis and X-ray diffraction further confirmed the presence of AgNPs. Hydrodynamic size and zeta potential of AgNPs were observed to be 43.9 nm and -7.12 mV, respectively. Fourier-transform infrared spectroscopy analysis revealed the presence of characteristic amide proteins and aromatic functional groups. Thin-layer chromatography (TLC) and Gas chromatography-mass spectroscopy (GC-MS) analysis revealed the presence of fatty acids in the wings extract that may be responsible for biosynthesis and stabilization of AgNPs. Further, SDS-PAGE of the insect wing extract protein showed the molecular weight of 49 kDa. M. mao silver nanoparticles (MMAgNPs) exhibit strong antioxidant, broad-range antibacterial and antifungal activities, (66.8 to 87.0%), broad-range antibacterial and antifungal activities was found with maximum zone of inhibition against Staphylococcus aureus MTCC 96 (35±0.4 mm) and Fusarium oxysporum f. sp. ricini (86.6±0.4) which signifies their biomedical and agricultural potential.

Introduction

Recent past has witnessed a significant dominance of nanotechnology in every field of human life like biomedical and engineering because it is efficient, bio-friendly, safe and economical [1]. In recent years, biologically synthesized nanoparticles are preferred over their chemical counterparts [2]. Among various nanoparticles, silver nanoparticles are widely accepted since they can be monitored easily by UV–Vis spectrophotometry [3]. Silver nanoparticles have small size, large surface area, high dispersive ability [4] and exhibit antimicrobial, anticancer, antidiabetic, antioxidant, anti-inflammatory properties [5] and are used in food processing industries, medical implants, ointment fabrication and emulsions [6]. So far, reports on green synthesis of AgNPs are from plant extracts, sea weeds, microorganisms/ metabolites and different biomaterials [710] are reported. However, there are no reports from wings of Mang Mao insects that are abundantly available and rich in proteins, polysaccharides and lipids. Previous studies show that wings (lipid components) of various insect species show bactericidal mechanisms of nanostructured surfaces [11]. M. mao (winged termite) are eusocial insects with three groups (soldiers, workers and queen) and are commonly observed during rainy season (Fig 1A).

Fig 1.

Fig 1

(a) Mang Mao insect. (b) (1) Silver nitrate solution; (2) Mang Mao wings extract; (3) Silver nanoparticles; (c) UV-Vis spectra of AgNPs synthesized by Mang Mao wings extract.

After heavy rain, these insects fly out in huge numbers during nights and get assembled near lights, and following day, shed their wings and get killed due to lack of moisture. Mang Mao insects are used as edible nutrient-rich and tasty food in most of the Asian countries and in rural areas they are also used to feed chickens, fish, birds and geckos. The wings of dead M. mao have a great environmental concern as it is a big waste. Insects’ wings can be utilized as an alternative source for chitin and to synthesize nanoparticles [6,8]. Hence, the present study focused on biofabrication of AgNPs by using M. mao wings extract and evaluate antioxidant and antimicrobial potential.

Materials and methods

Collection and preparation of Mang mao wings

M. mao wings used in the present study were collected during rainy season from Osmania University (17.4135° N, 78.5287° E) campus, Hyderabad, India. The wings were collected in sterilized glass beakers, aseptically washed twice with distilled water to remove dust particles, dried and stored at room temperature in air tight containers.

Synthesis of silver nanoparticles (AgNPs)

Biosynthesis of AgNPs from Mang Mao wings extract was carried out, following methodology given by Lateef et al. [8] M. mao wings (0.1 g) were hydrolyzed using 20 mL of 0.1 M NaOH at 90 oC for 1 hour, cooled and the hydrolyzed solution was centrifuged at 8000 rpm for 10 minutes. Supernatant was collected, pH adjusted to 7 from which 1 mL of wing extract was added to 49 mL of 1 mM silver nitrate (AgNO3) solution taken in 100 mL beaker and incubated at 28±1°C for 30 minutes under static conditions for synthesis of AgNPs. Absorption maxima was measured at 200 to 700 nm using UV-Vis spectrophotometer (HITACHI U-2900, Japan) to characterize the Mang Mao silver nanoparticles (MMAgNPs) and later on the sample was centrifuged at 8000 rpm for 10 min followed by pellet wash with acetone and air dried for further studies.

Optimization of MMAgNPs synthesis

Effect of various process parameters on MMAgNPs synthesis was optimized using one variable at a time (OVAT) approach [9] where, the effect of a single parameter was evaluated initially and concentration obtained was used as a standard for all the subsequent steps. Parameters optimized using OVAT included AgNO3 (1 to 3 mM), the concentration ratio of silver nitrate and M. mao wings extract (1:1, 1:3, 1:5), pH (3 to 11) and reaction time (0 to 30 minutes). The presence of AgNPs in the resultant solution was detected by the absorbance maxima as mentioned above.

Stability study

Above optimized MMAgNPs were incubated at 28±1°C in dark conditions for 119 days and absorbance maxima was measured weekly once to determine its stability.

Characterization of MMAgNPs

Scanning electron microscopy (SEM) of the sample was performed by dispersion of the sample in aluminum foil at 5.0 kV operating voltage using JSM-7500F and images were recorded at different magnifications. Energy-dispersive X-ray (EDX) analysis was performed by using Hitachi S-3400 NSEM instrument equipped with Thermo EDX for which the synthesized MMAgNPs were dehydrated and coated on carbon film. X-ray diffraction (XRD) was carried out by drop-coating MMAgNPs solution onto a glass substrate and diffraction was measured using Philips X’Pert Pro X-Ray diffractometer. The average crystal size of nanoparticles was estimated using Scherrer equation i.e., D = K λ/β cosƟ [10]. The particle size distribution and zeta potential of MMAgNPs was analyzed in triplicate by electrophoretic light scattering at 25°C, 150 V (DelsaMax PRO Light Scattering Analyzer, Beckman Coulter, United States) in distilled water. Functional groups were determined by FTIR spectroscopy (Bruker Tensor 27) and spectra were measured in the range 4000–400 cm−1 wavelength using KBr pellet as background reference.

Size and zeta potential of the silver nanoparticles were determined by Malvern Zetasizer ZEN 3600 (United Kingdom). This instrument allows the measurement of particle sized distribution in the range 2 nm–3 nm [12].

Thin layer chromatography and Gas chromatography mass spectroscopy

Reducing compounds of M. mao wings extract was analyzed by TLC on silica gel plates (silica gel 60 F254, Merck, Germany) with mobile phase (chloroform: methanol {97:3}), and chromatogram was examined under UV fluorescence (11). GC-MS analysis of Mang Mao wings extract was performed according to method as described by Ha et al. [12].

Extraction and purification of protein from M.mao wings

The protein from Mang Mao wings were extracted as per Zhang et al. [13] and precipitated using ammonium sulfate till approximately 30% saturation and incubated overnight at 4°C followed by centrifugation. Pellet obtained was suspended in 0.05 M Tris-HCl buffer (pH– 7), with 0.1 M NaCl, and dialyzed against the same buffer for 24 h. The crude protein was filtered using a 0.22 μm membrane filter and then subjected to column chromatography using silica gel and used for synthesis of AgNPs. Crude and purified proteins were further analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and its molecular weight (Broad range 11 to 245 kDa, BioLabs, England) was determined [14].

Antioxidant and antimicrobial activity of MMAgNPs

DPPH free radical scavenging activity

Antioxidant activity of MMAgNPs was evaluated by 2, 2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay [11]. Reaction mixture consisted of equal volumes (1:1 w/v) of different concentrations of the synthesized MMAgNPs (100 to 500 μg mL-1 in water), to which 1 mL of 0.5 mM DPPH in ethanol solution was added. The reaction mixture was incubated in dark for 30 min at 28±2°C. The absorbance is measured at 517 nm by UV-Vis spectrophotometer. Standard used was ascorbic acid to determine scavenging activity which was calculated by following equation.

%scavengingactivity=[(AcontrolAtest)/Acontrol]x100

Reducing power assay

Ferric reducing power assay was determined with 1 mL of the synthesized MMAgNPs, 2.5 mL of 0.2 M phosphate buffer (pH–6.6) and 2.5 mL of 1% potassium ferricyanide incubated at 50 oC for 20 minutes followed by cooling at room temperature. Then 2.5 mL of 10% trichloroacetic acid was added to the above mix and centrifuged at 8000 rpm for 20 min. Supernatant was mixed with distilled water in 1:1 v/v ratio and 1 mL of 0.1% ferric chloride was added and further incubated at 28± 2°C for 10 min. Spectrophotometric absorbance of the resultant solution was measured at 700 nm. Increase in absorbance of reaction mixture indicated reducing activity of sample.

Determination of antibacterial and antifungal activity of MMAgNPS

Antibacterial activity of MMAgNPs was tested against bacteria namely Staphylococcus aureus MTCC 96, Pseudomonas aeruginosa MTCC 424, Escherichia coli MTCC 43, Klebsiella pneumonia MTCC 9751 and Achromobacter xylosoxidans SHB 204 (obtained from our lab) and antifungal activity was tested against Fusarium oxysporum f. sp. ricini, Fusarium oxysporum f. sp. lycopersici MTCC 10270, Phytophthora nicotianae, Fusarium sacchari and Colletotrichum falcatum using agar well diffusion method [15,16] using nutrient and potato dextrose agar plates (Fungal strains were obtained from Indian Institute of Oil Seeds Research (IIOR) Rajendranagar,, Hyderabad, TS, India and Regional Agricultural Research Station (RARS), Anakapalle, AP, India. Aliquots of 50 μL of different concentrations of MMAgNPs (10 μg mL-1, 5 μg/mL, 2.5 μg mL-1 and 1.25 μg mL-1) were separately added in the wells. The inoculated bacterial and fungal plates were incubated at 37°C for 24 h and 28°C for 72–96 h respectively and observed for inhibition of growth.

Statistical analysis

All the experiments were performed in triplicates, repeated twice and data was expressed as means ± standard deviation using IBM Corporation. 2012 Statistics, and graphs were drawn using Origin Pro 2015 [17,18].

Results and discussion

Synthesis of MMAgNPs

M. mao wings extract, rich in proteins, chitin and lipids was used for the reduction of AgNO3 into AgNPs. The change in color of reaction mixture from yellow to dark brown after 30 minutes incubation (Fig 1) indicated synthesis of MMAgNPs. The intensity of dark brown colour change indicated AgNPs formation from silver salt which is due to excitation of surface plasmon resonance (SPR) effect [19,20].

Optimization of MMAgNPs synthesis

During the optimization study using OVAT, AgNO3 when used at 1 mM concentration showed maximum absorption at 430 nm, indicated active formation of MMAgNPs. Further increase in the concentration of AgNO3 resulted in decreased absorption (Fig 2A). These results were in agreement with the previous investigations carried out as per Veerasamy et al. [17]. When, M. mao wings extract (1 mL) was added to AgNO3 solution (1 mM), rapid conversion to brown color observed within 30 minutes, indicated active MMAgNPs synthesis (Fig 2B). The increased color change of brown color was directly proportional to the incubation period which is due to reduction of AgNO3 and excitation of SPR [19]. The absorption peak varied with different pH and it ranged between 390–470 nm (Fig 2C). The MMAgNPs formation was found to be slow at acidic pH (2–5). At neutral pH (7) absorption maxima was observed at 430 nm and the reaction started as soon as AgNO3 was added to the reaction mixture. The change in color to brown was observed within 30 minutes which indicated MMAgNPs synthesis (Fig 2D).

Fig 2.

Fig 2

(a) UV–vis spectra of aqueous silver nitrate concentration. (b) Concentration ratio of Mang Mao extract with 1 mM silver nitrate. (c) Different pH range. (d) Different time intervals.

Further, beyond pH 7 MMAgNPs resulted in aggregation and fall in flocculation. Previous studies revealed that at alkaline pH, Ag (I) ions in solution partly hydrolyze to form bioorganic-Ag(OH)x or bioorganic-Ag(NH3)2 complex on the surface of the particle and AgOH/Ag2O colloid in the medium [21]. The characteristic absorption peak at 430 nm corresponded to SPR of AgNPs previously reported by Bahrami-Teimoori et al. [22], which thereby confirmed the synthesis of MMAgNPs. This indicates the significance of M. mao wings extract in the reduction of metal salts to their respective metal nano-particles.

Stability study of MMAgNPs

The stability of MMAgNPs was monitored up to 119 days (weekly once) and there was no change in absorbance at 430 nm (S1 Fig). This indicated strong stability of biosynthesized MMAgNPs which might be attributed to presence of carboxylate group in proteins that may result in stable nanoparticles [23].

Characterization of MMAgNPs

UV–visible spectroscopic analysis of MMAgNPs

Nanoparticles synthesis is generally found to occur due to excitation of surface plasmon resonance (SPR) [24]. The strongest absorption peak observed at 430 nm (Fig 1C) corresponds to SPR of AgNPs which is in accordance with previous reports [25,26].

SEM and EDX analysis of MMAgNPs

SEM analysis revealed the occurrence of MMAgNPs in a spherical shape and their size ranged between 40 to 60 nm. The results showed that variation of pH in reaction mixture altered the nanoparticles size (Fig 3), however, at neutral pH the nanoparticles were uniform (Fig 3C). Reddy et al. [27] reported that biosurfactants (surfactin) used for AgNPs synthesis altered the pH and decreased AgNPs size (9.7 to 4.9 nm) and at pH-9 the nano-particles were uniform. However, MMAgNPs were not uniform in size, and variations in nanoparticle’s size were reported by Ahmed et al. [28] and Narayan and Dipak [29] using plant and seaweed extracts. The EDX spectra of MMAgNPs revealed the presence of characteristic signals of silver ions at 3keV (S2 Fig) similar to those observed with chemically synthesized AgNPs. The emission energy at 3 keV indicated the reduction of silver ions to elemental silver [30].

Fig 3.

Fig 3

SEM images (a) pH-3. (b) pH-5. (c) pH-7. (d) pH-9. (e) pH-11.

XRD analysis of MMAgNPs

The XRD pattern of MMAgNPs showed the diffraction peaks at 2θ values of 32.6°, 46.57°, 67.8° and 77.04° which further confirmed crystalline nature of MMAgNPs (Fig 4) and corresponded to standard JCPDS file No. 04–0783 [31]. Broadening in peaks occurred due to smaller particle size, which reflects the experimental conditions on nucleation and growth of crystal nuclei [32]. According to Debye Scherrer equation, the average nanoparticle size in this study was found to be 32 nm, which was relatively similar as described earlier by Sri Ramkumar et al. [33].

Fig 4. XRD pattern of biosynthesized silver nanoparticles using Mang Mao wings extract.

Fig 4

Zeta potential

Particle size distribution and zeta potential of MMAgNPs was depicted in S3(A) & S3(B) Fig. Average particle size of synthesized MMAgNPs was 43.9 nm and zeta potential -7.12 mV. The negative charges on AgNPs might be due to Mang Mao wings extract covering on nanoparticles. For the determination of overall surface charges on nanoparticles zeta potential analysis was applied.

Stability and prevention of aggregate formation, attributed to repulsions, due to same charge is provided by positive or negative charge on surface of nanoparticles [34]. This indicates better stability of nanoparticles and prevents agglomeration [35]. Hydrodynamic size and zeta potential of MMAgNPs in this study, corroborate with recent report of Badoei-dalfard et al. [36] hydrodynamic size (30–50 nm) of AgNPs synthesized using uricase from Alcaligenes faecalis GH3 and zeta potential (-4.6 mV) using Madhuca longifolia flower extract [34].

FTIR analysis

Identification of bond linkages and functional groups involved in reduction and stability AgNPs synthesis were performed using FTIR. The FTIR spectra of M. mao wings extract and synthesis of AgNPs is shown in Fig 5. M. mao wings extract bands observed at 3383, 1740, 1641, 1369, 1211, 1049 and 892 cm−1, which is related to stretching vibrations of OH of carboxylic acids, C = O of ester fatty acid group, C = O of amide band, C-H of aliphatic bending group, C-O-C of polysaccharide, C-O stretching and–C = O of inorganic carbonate respectively.

Fig 5. FTIR pattern of the Mang Mao wings extract and synthesized MMAgNPs.

Fig 5

After reduction, AgNPs form the bands observed at 3291, 2885–2828, 1801, 1643, 1552, 1403, 1322, 1046 and 650 cm−1 which is related to stretched vibrations of OH of carboxylic acids, C-H of aliphatics, C = O of anhydride, C = O of amide bond, C = C aromatic, CH of aliphatic bending group, NO2 stretch, C-O stretching and N-H stretch respectively. Biomolecules present in the M. mao wings extract might be responsible for synthesis and stability of AgNPs. The characteristic FTIR peaks observed in the present study were similar to those reported by Dhanasekaran et al. [37] and Usha et al. [38]. Similar results were reported by Selvakumar et al. [39] and Soman and Ray [40] where synthesis is performed using Acalypha hispida and Ziziphus oenoplia (L.) leaf extract as reducing and stabilizing agent.

TLC of Mang Mao wings extract

TLC analysis of Mang Mao wings extract corresponded to Rf value 0.96 which is similar to insect chemicals based on previous studies [41]. These chemicals may also be responsible for biofabrication of MMAgNPs (Fig 6A).

Fig 6.

Fig 6

(a) TLC of Mang Mao wings extract: (1) UV visualization, (2) Ninhydrin reagent. (b) SDS-PAGE analysis of Mang Mao wings extract protein; Lane 1. Molecular size marker; lane 2. Crude protein; lane 3. Purified protein (46 kDa) responsible for active biosynthesized MMAgNPs.

Gas chromatography mass spectrometric analysis

GC–MS data revealed that M.mao wings extract have 30 major compounds with their molecular weight shown in Table 1. Major components of wings are comprised by aliphatic hydrocarbons and are 9-Octadecynoic acid (16.9%), Nonadecanoic acid (11.4), Ethyl 9-octadecenoate (9.8%), Heptacosanoic acid (4.9%), 1-[2-Deoxy-.beta.-d-erythro-pentofuranosyl] p (4.6%), Hexadecanoic acid (3.7%), 3-Nonyn-2-ol (3.7%), 8-acetoxy-6-benzenesulfonyl-2-th (3.2%), Ethanone (3.1%), 1,5-Cyclooctadiene (3%). These components may be responsible for the reduction and capping of silver ions. Octadecynoic acid and hexadecanoic acid are fatty acids that are widely observed in insects, plants and animals [4244]. These fatty acids are situated within wings membrane under the epicuticular surface [13,44]. The components present in Mang Mao wings extract corresponds with that of previous reports on nanoparticles synthesis [39,45,46].

Table 1. GC-MS analysis of M. mao wings extract.
Peak Retention Time Peak Area Area (%) Peak Height Base m/z Compounds present
1 4.293 16038 2.80 5062 43.95 Aspidospermidine-3-carboxylic acid, 2,3-dide
2 7.462 9307 1.63 4568 43.90 Histidine, 4-nitro-
3 10.765 8152 1.42 4045 333.80 trans-5-Hydroxytricyclo[4.4.0.0(3,8)]-4-carbo
4 11.670 6678 1.17 1309 42.90 5-Pyrimidinecarboxylic acid, hexahydro-5-(1-
5 13.051 18391 3.21 4402 43.95 Acetic acid, 8-acetoxy-6-benzenesulfonyl-2-th
6 15.405 6944 1.21 3476 43.90 p-Chlorocinnamide
7 16.978 13566 2.37 4121 58.90 2,5,7-Metheno-3H-cyclopenta[a]pentalen-3-o
8 17.055 17249 3.01 1863 40.00 1,5-Cyclooctadiene
9 17.287 18141 3.17 5052 43.90 Ethanone, 1-(4-pyridinyl)-, oxime
10 17.320 26832 4.69 5182 43.90 1-[2-Deoxy-.beta.-d-erythro-pentofuranosyl]p
11 17.554 65501 11.44 26163 88.00 Nonadecanoic acid, ethyl ester
12 19.309 96933 16.94 43045 66.95 9-Octadecynoic acid
13 19.366 56171 9.81 24672 54.95 Ethyl 9-octadecenoate, (E)-
14 19.405 7072 1.24 6466 43.95 3-p-Toluenesulfonyl-7-hydroxymethyl-9-hydr
15 19.634 21515 3.76 12272 330.11 Hexadecanoic acid
16 21.610 12089 2.11 3085 43.95 Scilliroside
17 21.909 8632 1.51 3507 66.90 Cyclohexanol, 2-butyl-
18 22.146 10102 1.77 3802 43.95 6-Benzenesulfonyl-2-oxa-6-aza-adamantane-
19 22.980 9703 1.70 6415 73.10 Heptasiloxane, hexadecamethyl-
20 23.045 10758 1.88 3399 44.00 N-[2,2,2-Trifluoro-1-(isopropylamino)-1-(trifl
21 23.390 10906 1.91 1134 43.90 Carboethoxy-1-piperazinethiocarboxylic acid
22 23.520 6339 1.11 2346 43.85 Acetamide, 2,2-dichloro-
23 24.200 21662 3.78 3185 43.05 3-Nonyn-2-ol
24 24.830 9090 1.59 4327 53.00 2-Chloro-3-(chloromethyl)-4-pentenoic acid,
25 24.923 13120 2.29 4364 41.00 Butanoic acid, 3-bromo-, ethyl ester
26 26.067 14088 2.46 3903 42.95 3-Cyclopentene-1-propanoic acid, 5-(methox
27 26.337 28275 4.94 6648 43.05 Heptacosanoic acid, methyl ester
28 26.526 7775 1.36 3530 40.10 1(2H)-Naphthalenone, 4-ethoxyoctahydro-, tr
29 27.795 13904 2.43 3102 95.90 2-Monooleoylglycerol trimethylsilyl ether
30 30.559 7400 1.29 4819 73.00 3-Isopropoxy-1,1,1,5,5,5-hexamethyl-3-(trime

Extraction and purification of Mang Mao wings extract

SDS-PAGE analysis revealed the presence of different cellular proteins with molecular weights that ranged between 22–245 kDa. Protein band corresponded to 46 kDa (Fig 6B) was found to act as a capping agent for stabilization of the MMAgNPs.

Khan and Ahmad [47] reported, purified sulfite reductase enzyme with molecular weight of 43 kDa to be responsible for gold nanoparticles stability and synthesis. Kumar et al. [48] also claimed protein of 35.6 kDa is responsible for biosynthesis and capping agent of gold nanoparticles. However, further studies are required towards characterization and identification of this protein to validate this result.

Antioxidant activity of MMAgNPs

MMAgNPs exhibited DPPH scavenging activity in the range of 66.8 to 87.0% and in case of ascorbic acid it was found to be in the range of 89.7 to 95.5% (Fig 7A). Difference in the activity can be attributed to a different functional group attached to them. MMAgNPs showed good ferric ion reducing activity which was comparable to that of standard ascorbic acid (Fig 7B). Results obtained from this study suggested the use of biosynthesized MMAgNPs as natural antioxidants. Free radical scavenging activity of MMAgNPs is mainly due to the donation of hydrogen molecules, such as proteins, polyphenols and other biomolecules present in the colloidal solution of AgNPs [26]. Radical scavenging activity of AgNPs is due to presence of bioreductant molecules on surface of nanoparticles increasing the surface area for antioxidant activity [12]. Therefore, these MMAgNPs can be employed as a natural antioxidant in the pro-oxidants, antioxidants and to balance reactive oxygen species (ROS) levels. Previous study of AgNPs synthesized using Catharanthus roseus showed radical scavenging activity and prevented human cell damage and degenerative diseases [49]. This work concludes the use of MMAgNPs as potential agent of antioxidant formulations in biomedical/ pharmaceutical areas.

Fig 7.

Fig 7

Antioxidant activity: (a) DPPH scavenging activity. (b) Ferric reducing antioxidant activity.

Antimicrobial activity of MMAgNPs

Biosynthesized MMAgNPs exhibited potential antibacterial and antifungal activity. MMAgNPs showed maximum zone of inhibition of 35±0.4 mm and minimum zone of inhibition of 16±0.2 mm against Staphylococcus aureus MTCC 96 and Achromobacter xylosoxidans SHB 204 respectively, when used at a concentration of 10 μg mL-1 and the results of the same are shown in Figs 8 and S4. Whereas, maximum percentage of inhibition of 86.6±0.4 mm and minimum percentage of inhibition of 62.7±0.4 mm was recorded against Fusarium oxysporum f. sp. ricini and Colletotrichum falcatum respectively when the MMAgNPs were used at a concentration of 10 μg mL-1. MMAgNPs served as potential antibacterial, antifungal agents and may emerge as an alternative to conventional antibiotics [50].

Fig 8. Antimicrobial activity of synthesized MMAgNPs.

Fig 8

These AgNPs due to their small size can adhere to bacterial cell membrane, increase permeability and can cause structural changes in bacteria. In case of fungi, AgNPs disrupt the membrane integrity and fungal spores leading to cell death [51]. Some researchers claimed that AgNPs enter the microorganisms and can cause damage by interacting with DNA and proteins, resulting in apoptosis [52].

Conclusion

In this study, we explored M. mao wings extract as an eco-friendly, cost-effective and novel biomaterial for biofabrication of AgNPs. The synthesized AgNPs were spherical, 40–60 nm in size and are highly crystalline nature. This is the first report on use of M. mao (seasonal insect) wings with metal chelating potential can be used as natural reducing agents for the synthesis of nanoparticles. MMAgNPs exhibit strong antioxidant (66.8 to 87.0%) and antimicrobial activities was found maximum zone of inhibition against Staphylococcus aureus MTCC 96 (35±0.4 mm) and Fusarium oxysporum f. sp. ricini (86.6±0.4). Antioxidant and antimicrobial properties of MMAgNPs may further widen their application in the biomedical and agricultural sectors.

Supporting information

S1 Fig. Stability of MMAgNPs.

(DOC)

S2 Fig. Energy dispersive X-ray analysis of the synthesized MMAgNPs.

(DOC)

S3 Fig

(a) Characterization of MMAgNPs by DLS size distribution. (b) Characterization of MMAgNPs by zeta potential analysis.

(DOC)

S4 Fig

(a) Antibacterial activity of MMAgNPs. (b) Antifungal activity of MMAgNPs.

(DOC)

S1 File

(PDF)

S2 File

(PDF)

S1 Raw Image. Gel image for Fig 6.

(TIF)

Acknowledgments

Author Parameshwar J and Hameeda Bee are thankful to UGC-RGNF and DST-PURSE. Authors thank Indian Institute of Oil Seeds Research (IIOR) Rajendranagar, TS, India and Regional Agricultural Research Station (RARS), Anakapalle, A.P., India for providing fungal cultures for the present study. The authors extend their appreciation for King Saud University, Riyadh, KSA.

Data Availability

All relevant data are within the manuscript file and supplementary file.

Funding Statement

This study was supported by UGC-RGNF in the form of a fellowship (F1-17.1/2014-15/RGNF-2014-15-SC-TEL-86198) to JP, DST-PURSE in the form of funding (C-DST-PURSE-II/43/2018) awarded to HB and the Deanship of Scientific Research at King Saud University through project No. (RG-1440-053) awarded to EAE. Kalam Biotech Pvt. Ltd provided support in the form of a salary for YK. The specific roles of these authors are articulated in the ‘author contributions’ section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Abdelghany T. M., Aisha M. H. Al-Rajhi, Mohamed A. Al Abboud, Alawlaqi M. M., Ganash Magdah A., Eman A. M. Helmy, et al. Recent advances in green synthesis of silver nanoparticles and their applications: about future directions. A Review. Bionanoscience. BioNanoScience; 2018;8: 5–16. 10.1007/s12668-017-0413-3 [DOI] [Google Scholar]
  • 2.Das CGA, Kumar VG, Dhas TS, Karthick V, Govindaraju K, Joselin JM, et al. Antibacterial activity of silver nanoparticles (biosynthesis): A short review on recent advances. Biocatal Agric Biotechnol. Elsevier Ltd; 2020;27: 101593. 10.1016/j.bcab.2020.101593 [DOI] [Google Scholar]
  • 3.Mohanta YK, Nayak D, Biswas K, Singdevsachan SK, Abd Allah EF, Hashem A, et al. Silver nanoparticles synthesized using wild mushroom show potential antimicrobial activities against food borne pathogens. Molecules. 2018;23: 1–18. 10.3390/molecules23030655 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Basu S, Maji P, Ganguly J. Rapid green synthesis of silver nanoparticles by aqueous extract of seeds of Nyctanthes arbor-tristis. Appl Nanosci. Springer Berlin Heidelberg; 2016; 1–5. 10.1007/s13204-015-0407-9 [DOI] [Google Scholar]
  • 5.Govindappa M, Hemashekhar B, Arthikala MK, Ravishankar Rai V, Ramachandra YL. Characterization, antibacterial, antioxidant, antidiabetic, anti-inflammatory and antityrosinase activity of green synthesized silver nanoparticles using Calophyllum tomentosum leaves extract. Results Phys. 2018;9: 400–408. 10.1016/j.rinp.2018.02.049 [DOI] [Google Scholar]
  • 6.Rafique M, Sadaf I, Rafique MS, Tahir MB. A review on green synthesis of silver nanoparticles and their applications. Artif Cells, Nanomedicine Biotechnol. Informa UK Limited, trading as Taylor & Francis Group; 2017;45: 1272–1291. 10.1080/21691401.2016.1241792 [DOI] [PubMed] [Google Scholar]
  • 7.Siddiqi KS, Husen A, Rao RAK. A review on biosynthesis of silver nanoparticles and their biocidal properties. J Nanobiotechnology. BioMed Central; 2018;16. 10.1186/s12951-018-0334-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lateef A, Ojo SA, Azeez MA, Asafa TB, Yekeen TA, Akinboro A, Oladipo I. C., et al. Cobweb as novel biomaterial for the green and eco-friendly synthesis of silver nanoparticles. Appl Nanosci. Springer Berlin Heidelberg; 2016;6: 863–874. 10.1007/s13204-015-0492-9 [DOI] [Google Scholar]
  • 9.Rane AN, Baikar V V., Ravi Kumar D V., Deopurkar RL. Agro-industrial wastes for production of biosurfactant by Bacillus subtilis ANR 88 and its application in synthesis of silver and gold nanoparticles. Front Microbiol. 2017;8: 1–12. 10.3389/fmicb.2017.00001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Belle Ebanda Kedi P, Eya’ane Meva F, Kotsedi L, Nguemfo EL, Bogning Zangueu C, Ntoumba AA, et al. Eco-friendly synthesis, characterization, in vitro and in vivo anti-inflammatory activity of silver nanoparticle-mediated Selaginella myosurus aqueous extract. Int J Nanomedicine. 2018; Volume 13: 8537–8548. 10.2147/IJN.S174530 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Linklater Denver P., Baulin Vladimir A., Juodkazis Saulius, Crawford Russell J., Stoodley Paul, and Ivanova Elena P. Mechano-bactericidal actions of nanostructured surfaces. Nature Reviews Microbiology. 2020; 1–15. 10.1038/s41579-019-0302-6 [DOI] [PubMed] [Google Scholar]
  • 12.Chandrasekhar N, Vinay SP. Yellow colored blooms of Argemone mexicana and Turnera ulmifolia mediated synthesis of silver nanoparticles and study of their antibacterial and antioxidant activity. Appl Nanosci. Springer Berlin Heidelberg; 2017;7: 851–861. 10.1007/s13204-017-0624-5 [DOI] [Google Scholar]
  • 13.Ha S, Nguyen T, Webb HK, Hasan J, Tobin MJ, Crawford RJ, et al. Dual role of outer epicuticular lipids in determining the wettability of dragonfly wings. Colloids Surfaces B Biointerfaces. Elsevier B.V.; 2013;106: 126–134. 10.1016/j.colsurfb.2013.01.042 [DOI] [PubMed] [Google Scholar]
  • 14.Zhang QX, Zhang Y, Shan HH, Tong YH, Chen XJ, Liu FQ. Isolation and identification of antifungal peptides from Bacillus amyloliquefaciens W10. Environ Sci Pollut Res; 2017;24: 25000–25009. 10.1007/s11356-017-0179-8 [DOI] [PubMed] [Google Scholar]
  • 15.Simpson RJ. SDS-PAGE of Proteins. Cold Spring Harb Protoc.2006: pdb.prot4313. 10.1101/pdb.prot4313 [DOI] [PubMed] [Google Scholar]
  • 16.Javan S, Djahaniani H, Nabati F, Hekmati M. Characterization and the evaluation of antimicrobial activities of silver nanoparticles biosynthesized from Carya illinoinensis leaf extract. Heliyon. Elsevier Ltd; 2020;6: e03624. 10.1016/j.heliyon.2020.e03624 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Seifert E. OriginPro 9.1: Scienti fi c Data Analysis and Graphing Software—Software Review. J Chem Inf Model. 2014;54: 1552–1552. 10.1021/ci500161d [DOI] [PubMed] [Google Scholar]
  • 18.Jakinala P, Lingampally N, Kyama A, Hameeda B. Enhancement of atrazine biodegradation by marine isolate Bacillus velezensis MHNK1 in presence of surfactin lipopeptide. Ecotoxicol Environ Saf. Elsevier Inc.; 2019;182: 109372. 10.1016/j.ecoenv.2019.109372 [DOI] [PubMed] [Google Scholar]
  • 19.Mohamed E, Abdelhameed E, Huseein M. Green biosynthesis of silver nanoparticles by Aspergillus niger and its antiamoebic effect against Allovahlkampfia spelaea trophozoite and cyst. Exp Parasitol. Elsevier Inc.; 2020; 108031. 10.1016/j.exppara.2020.108031 [DOI] [PubMed] [Google Scholar]
  • 20.Veerasamy R, Xin TZ, Gunasagaran S, Xiang TFW, Yang EFC, Jeyakumar N, et al. Biosynthesis of silver nanoparticles using mangosteen leaf extract and evaluation of their antimicrobial activities. J Saudi Chem Soc. King Saud University; 2011;15: 113–120. 10.1016/j.jscs.2010.06.004 [DOI] [Google Scholar]
  • 21.Ghaffari-Moghaddam M, Hadi-Dabanlou R. Plant mediated green synthesis and antibacterial activity of silver nanoparticles using Crataegus douglasii fruit extract. J Ind Eng Chem. The Korean Society of Industrial and Engineering Chemistry; 2014;20: 739–744. 10.1016/j.jiec.2013.09.005 [DOI] [Google Scholar]
  • 22.Bahrami-Teimoori B, Nikparast Y, Hojatianfar M, Akhlaghi M, Ghorbani R, Pourianfar HR. Characterisation and antifungal activity of silver nanoparticles biologically synthesised by Amaranthus retroflexus leaf extract. J Exp Nanosci. Taylor & Francis; 2017;12: 129–139. 10.1080/17458080.2017.1279355 [DOI] [Google Scholar]
  • 23.Kumar V, Gundampati RK, Singh DK, Jagannadham M V., Sundar S, Hasan SH. Photo-induced rapid biosynthesis of silver nanoparticle using aqueous extract of Xanthium strumarium and its antibacterial and antileishmanial activity. J Ind Eng Chem. The Korean Society of Industrial and Engineering Chemistry; 2016;37: 224–236. 10.1016/j.jiec.2016.03.032 [DOI] [Google Scholar]
  • 24.Tóth IY. Silver nanoparticles: aggregation behavior in biorelevant conditions and its impact on biological activity. Int J Nanomedicine. 2019;14: 667–687. 10.2147/IJN.S185965 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kagithoju S, Godishala V, Nanna RS. Eco-friendly and green synthesis of silver nanoparticles using leaf extract of Strychnos potatorum Linn.F. and their bactericidal activities. 3 Biotech. Springer Berlin Heidelberg; 2015;5: 709–714. 10.1007/s13205-014-0272-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Netala VR, Kotakadi VS, Bobbu P, Gaddam SA, Tartte V. Endophytic fungal isolate mediated biosynthesis of silver nanoparticles and their free radical scavenging activity and anti microbial studies. 3 Biotech. Springer Berlin Heidelberg; 2016;6: 1–9. 10.1007/s13205-015-0313-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Reddy AS, Chen CY, Baker SC, Chen CC, Jean JS, Fan CW, et al. Synthesis of silver nanoparticles using surfactin: A biosurfactant as stabilizing agent. Mater Lett. Elsevier B.V.; 2009;63: 1227–1230. 10.1016/j.matlet.2009.02.028 [DOI] [Google Scholar]
  • 28.Ahmed S, Saifullah, Ahmad M, Swami BL, Ikram S. Green synthesis of silver nanoparticles using Azadirachta indica aqueous leaf extract. J Radiat Res Appl Sci. Elsevier Ltd; 2016;9: 1–7. 10.1016/j.jrras.2015.06.006 [DOI] [Google Scholar]
  • 29.Narayan S, Dipak S. Green synthesis of silver nanoparticles using fresh water green alga Pithophora oedogonia (Mont.) Wittrock and evaluation of their antibacterial activity. Appl Nanosci. 2015; 703–709. 10.1007/s13204-014-0366-6 [DOI] [Google Scholar]
  • 30.Singh P, Kim YJ, Singh H, Wang C, Hwang KH, Farh ME, et al. Biosynthesis, characterization, and antimicrobial applications of silver nanoparticles. Int J Nanomedicine. 2015;10: 2567–2577. 10.2147/IJN.S72313 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Chowdhury S, Basu A, Kundu S. Green synthesis of protein capped silver nanoparticles from phytopathogenic fungus Macrophomina phaseolina (Tassi) Goid with antimicrobial properties against multidrug-resistant bacteria. Nanoscale Res Lett. 2014;9: 1–11. 10.1186/1556-276X-9-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Agnihotri S, Mukherji S, Mukherji S. Immobilized silver nanoparticles enhance contact killing and show highest efficacy: Elucidation of the mechanism of bactericidal action of silver. Nanoscale. 2013;5: 7328–7340. 10.1039/c3nr00024a [DOI] [PubMed] [Google Scholar]
  • 33.Sri Ramkumar SR, Sivakumar N, Selvakumar G, Selvankumar T, Sudhakar C, Ashok kumar B, et al. Green synthesized silver nanoparticles from: Garcinia imberti bourd and their impact on root canal pathogens and HepG2 cell lines. RSC Adv. Royal Society of Chemistry; 2017;7: 34548–34555. 10.1039/c6ra28328d [DOI] [Google Scholar]
  • 34.Patil MP, Singh RD, Koli PB, Patil KT, Jagdale BS, Tipare AR, et al. Antibacterial potential of silver nanoparticles synthesized using Madhuca longifolia flower extract as a green resource. Microb Pathog. Elsevier Ltd; 2018; 10.1016/j.micpath.2018.05.040 [DOI] [PubMed] [Google Scholar]
  • 35.Varadavenkatesan T, Selvaraj R, Vinayagam R. Green synthesis of silver nanoparticles using Thunbergia grandiflora flower extract and its catalytic action in reduction of Congo red dye. Mater Today Proc. Elsevier Ltd; 2019; 10–13. 10.1016/j.matpr.2019.05.441 [DOI] [Google Scholar]
  • 36.Badoei-dalfard A, Shaban M, Karami Z. Characterization, antimicrobial, and antioxidant activities of silver nanoparticles synthesized by uricase from Alcaligenes faecalis GH3. Biocatal Agric Biotechnol. Elsevier Ltd; 2019; 101257. 10.1016/j.bcab.2019.101257 [DOI] [Google Scholar]
  • 37.Dhanasekaran D, Latha S, Saha S, Thajuddin N, Panneerselvam A. Extracellular biosynthesis, characterisation and in-vitro antibacterial potential of silver nanoparticles using Agaricus bisporus. J Exp Nanosci. 2013;8: 579–588. 10.1080/17458080.2011.577099 [DOI] [Google Scholar]
  • 38.Usha Rani S, Jeeva Pandian K, Reddy BSR. Syntheses and characterisation of silver nanoparticles in the acrylate copolymers. J Exp Nanosci. 2009;4: 285–299. 10.1080/17458080903115338 [DOI] [Google Scholar]
  • 39.Selvakumar P, Sithara R, Viveka K, Sivashanmugam P. Green synthesis of silver nanoparticles using leaf extract of Acalypha hispida and its application in blood compatibility. J Photochem Photobiol B Biol. Elsevier B.V; 2018;182: 52–61. 10.1016/j.jphotobiol.2018.03.018 [DOI] [PubMed] [Google Scholar]
  • 40.Soman S, Ray JG. Silver nanoparticles synthesized using aqueous leaf extract of Ziziphus oenoplia (L.) Mill: Characterization and assessment of antibacterial activity. J Photochem Photobiol B Biol. Elsevier B.V.; 2016;163: 391–402. 10.1016/j.jphotobiol.2016.08.033 [DOI] [PubMed] [Google Scholar]
  • 41.Gołȩbiowski M, Boguś MI, Paszkiewicz M, Stepnowski P. Cuticular lipids of insects as potential biofungicides: Methods of lipid composition analysis. Anal Bioanal Chem. 2011;399: 3177–3191. 10.1007/s00216-010-4439-4 [DOI] [PubMed] [Google Scholar]
  • 42.Kuyumcu E. Natural product research: formerly natural product letters chemical composition and antimicrobial activity of essential oil of Achillea cretica L. (Asteraceae) from. Nat Prod Res. 2012;26: 37–41. [DOI] [PubMed] [Google Scholar]
  • 43.Buckner JS, Hagen MM. Triacylglycerol and phospholipid fatty acids of the silverleaf whitefly: composition and biosynthesis. Arch Insect Biochem Physiol. 2003;79: 66–79. 10.1002/arch.10086 [DOI] [PubMed] [Google Scholar]
  • 44.Wing Ivanova EP, Nguyen SH Webb HK, Hasan J Truong VK. Molecular organization of the nanoscale surface structures of the dragonfly Hemianax papuensis wing epicuticle. PLoS One. 2013;8. 10.1371/journal.pone.0067893 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Iijima M, Kawaharada Y, Tatami J. Effect of fatty acids complexed with polyethyleneimine on the flow curves of TiO 2 nanoparticle/toluene suspensions. Integr Med Res. Taibah University; 2016;4: 277–281. 10.1016/j.jascer.2016.05.003 [DOI] [Google Scholar]
  • 46.Dey A, Purkait MK. Effect of fatty acid chain length and concentration on the structural properties of the coated CoFe 2 O 4 nanoparticles. J Ind Eng Chem. The Korean Society of Industrial and Engineering Chemistry; 2014; 10.1016/j.jiec.2014.09.027 [DOI] [Google Scholar]
  • 47.Khan SA, Ahmad A. Enzyme mediated synthesis of water-dispersible, naturally protein capped, monodispersed gold nanoparticles; Their characterization and mechanistic aspects. RSC Adv. 2014;4: 7729–7734. 10.1039/c3ra43888k [DOI] [Google Scholar]
  • 48.Kumar SA, Abyaneh MK, Gosavi SW, Kulkarni SK, Ahmad A, Khan MI. Sulfite reductase-mediated synthesis of gold nanoparticles capped with phytochelatin. Biotechnol Appl Biochem. 2007;47: 191–5. 10.1042/BA20060205 [DOI] [PubMed] [Google Scholar]
  • 49.Al-Shmgani HSA, Mohammed WH, Sulaiman, Saadoon AH. Biosynthesis of silver nanoparticles from Catharanthus roseus leaf extract and assessing their antioxidant, antimicrobial, and wound-healing activities. Artif Cells, Nanomedicine Biotechnol. 2017;45: 1234–1240. 10.1080/21691401.2016.1220950 [DOI] [PubMed] [Google Scholar]
  • 50.Franci G, Falanga A, Galdiero S, Palomba L, Rai M, Morelli G, et al. Silver nanoparticles as potential antibacterial agents. Molecules. 2015;20: 8856–8874. 10.3390/molecules20058856 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Yugandhar P, Haribabu R, Savithramma N. Synthesis, characterization and antimicrobial properties of green-synthesised silver nanoparticles from stem bark extract of Syzygium alternifolium (Wt.) Walp. 3 Biotech. Springer Berlin Heidelberg; 2015;5: 1031–1039. 10.1007/s13205-015-0307-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Baker C, Pradhan A, Pakstis L, Pochan D, Shah SI. Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol. 2005;5: 244–249. 10.1166/jnn.2005.034 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Pradeep Kumar

16 Nov 2020

PONE-D-20-32626

Insect wing extract: A novel source for green synthesis of nanoparticles of antioxidant and antimicrobial potential

PLOS ONE

Dear Dr. Bee,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 31 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Pradeep Kumar

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

3. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

  • The name of the colleague or the details of the professional service that edited your manuscript

  • A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

  • A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

4. Thank you for stating the following in the Financial Disclosure section:

'Elsayed AHmed Elsayed received funds from Deanship of Scientific Research at King Saud University through research group No (RG-1440-053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.'

We note that one or more of the authors are employed by a commercial company: Kalam Biotech Pvt. Ltd

a. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

b. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.  

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

c. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: I Don't Know

Reviewer #3: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors,

Great congratulations on publishing this high-quality paper. There are some points should be considered in the final revision of this work.

1-Why the authors select this insect for synthesis of target particles?

2-What is the benefit of applied method in this study?

3-AgNPs are one of the sources of ROS production. How these particles may show such discussed benefits and scavenge free radicals. The provided proofs for this section of experimental assays is not acceptable and the authors must develop their idea regarding the antioxidant activity of AgNPs.

4-For what purpose these particles were synthesized? Would you please kindly discuss the clinical or industrial application of the synthesized particles regarding the method you applied in this study.

5-The authors should determine the synthesized particles are not toxic for human body. Please use MTT assay to determine the potential toxicity effects of these particles for living cells.

6-Figures were not prepared at high-resolution pixels. Please modify the source of figures to provide at least high-quality images for respective readers.

7-Please provide the screenshots of fungal assays as supplementary material. The effectiveness of synthesized particles for inhibition of fungal or bacterial growth on lab plates should be provided.

8-Please discuss the industrial application of the methodology of this paper plus its possible dangers for nearby environment.

Reviewer #2: Dear Author

The manuscript entitled "Insect wing extract: A novel source for green synthesis of nanoparticles of antioxidant and antimicrobial potential" looks interesting and needs to address following queries before considering for publication

Overall Query: Authors needs to justify the importance of insect wings as mentioned by authors "abundantly available and rich in proteins, polysaccharides and lipids" in introduction section. Need to add some imprtant findings and how the nanoparticles synthesized from targeted source will be better than available sources.

Secondaly authors can compare the bioactivities in normal extracts and nanoparticles that will also be interesting.

Minor corrections:

Title : Should be revised as

Silver nanoparticles from Insect wing extract : Biosynthesis and evaluation for antioxidant and antimicrobial potential

2)Abstract

Results of antioxidant and antimicrobial activity need to be mentioned

3)Introduction

Need details various source of biosynthesis of NPs and antioxidant and antimicrobial properties of AgNPs

4)Materials and Methods

Characterization of ------

Brief details of each method should be added

5)Statistical analysis

Cite some reference and source of software

6)Results and Discussion

Figure 4a and 5a and 5b can be given as supplementary figures

7)References

More recent and relevant references can be added

Reviewer #3: This is in reference to the manuscript entitled “Insect wing extract: A novel source for green synthesis of nanoparticles of antioxidant and antimicrobial potential (PONE-D-20-32626) submitted for publication in PLOS ONE journal.

The authors have presented an interesting study concerning green synthesis of nanoparticles. The topic has a novel approach. This is a very valid and interesting study, which can contribute to the body of knowledge. The paper is well-organized. The writing was sufficiently informative to deliver the message of the manuscript. A praiseworthy study was performed by the authors giving sufficient information on producing silver nanoparticles from insect wings.

Hence, I would suggest accepting the paper with minor corrections.

Mention the importance of some significant results obtained in the study in the conclusion section with an emphasis on its future applications.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Hassan Rasouli

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Mar 18;16(3):e0241729. doi: 10.1371/journal.pone.0241729.r002

Author response to Decision Letter 0


1 Jan 2021

Authors are thankful to reviewers for excellent review and comments/suggestions that helped in the improvement of the manuscript. The manuscript is revised in the light of suggestions of reviewers.

Reviewer #1

Dear authors,

Great congratulations on publishing this high-quality paper. There are some points should be considered in the final revision of this work.

1) Why the authors select this insect for synthesis of target particles?

Authors’ response: There are no reports from wings of Mang Mao insects that are abundantly available. Dead M. mao insects pose disposal and environmental concern and it can be reused for value added product. Recent literature also reveals insect wings has good source for antibacterial activity and now is added in the references.

2) What is the benefit of applied method in this study?

Authors’ response: The methodology used in this study of synthesis of silver nanoparticles, antimicrobial, antioxidant activity of a novel insect source signifies about the biological materials that can be used for nanoparticles and their further applications. In addition it adds on to cost effectiveness, economic feasibility and eco-friendly nature of use of insect wings for nanoparticle synthesis

3) AgNPs are one of the sources of ROS production. How these particles may show such discussed benefits and scavenge free radicals. The provided proofs for this section of experimental assays is not acceptable and the authors must develop their idea regarding the antioxidant activity of AgNPs.

Authors’ response: Agreed. Compounds present in the biological (plant, insect, microbial) extracts play important role in synthesis and stabilization of nanoparticles. These nanoparticles synthesized from insect wing extract showed antioxidant activity due to capped peptides and fatty acids.

4) For what purpose these particles were synthesized? Would you please kindly discuss the clinical or industrial application of the synthesized particles regarding the method you applied in this study.

Authors’ response: The nanoparticles were synthesized to determine their antimicrobial antioxidant potential. The results indicated that these nanoparticles can be used for clinical applications as we these NP exhibited antimicrobial activity against few bacterial pathogens, however, further studies are needed to confirm, their role.

5) The authors should determine the synthesized particles are not toxic for human body. Please use MTT assay to determine the potential toxicity effects of these particles for living cells.

Authors’ response: This study was limited to antimicrobial, cytotoxic and antioxidant aactivities of the synthesized MMAgNP.

6) Figures were not prepared at high-resolution pixels. Please modify the source of figures to provide at least high-quality images for respective readers.

Authors’ response: Agreed. Resolution of Figures is improved with PLOSONE app and now high resolution figures are included in the paper.

7) Please provide the screenshots of fungal assays as supplementary material. The effectiveness of synthesized particles for inhibition of fungal or bacterial growth on lab plates should be provided.

Authors’ response: Agreed. Screenshots of fungal and bacterial plates are now included as supplementary materials

8) Please discuss the industrial application of the methodology of this paper plus its possible dangers for nearby environment.

Authors’ response: Antioxidant and antimicrobial properties of insect wing extract nanoparticles may further widen their application in the biomedical and agricultural sectors. Use of insect wings for NP synthesis will solve the problems associated with disposal problem and can be better sources for antimicrobial potential, we dont see any negative impact on environment.

Reviewer #2: Dear Author

The manuscript entitled "Insect wing extract: A novel source for green synthesis of nanoparticles of antioxidant and antimicrobial potential" looks interesting and needs to address following queries before considering for publication

1) Authors needs to justify the importance of insect wings as mentioned by authors "abundantly available and rich in proteins, polysaccharides and lipids" in introduction section. Need to add some important findings and how the nanoparticles synthesized from targeted source will be better than available sources.

Authors’ response: The statement in the introduction “Mang mao insect wings are rich in proteins, polysaccharides and lipids” is supported by the observations that revealed the presence of different cellular proteins with molecular weights that ranged between 22-245 kDa. GC MS analysis also revealed the presence of different fatty acids and FTIR analysis reflected the presence of different functional groups present in MMAgNP.

2) Secondly authors can compare the bioactivities in normal extracts and nanoparticles that will also be interesting.

Authors’ response: Agreed. However, we focussed on the evaluation of bioactivities in nanoparticles.

Minor corrections

3) Title : Should be revised as Silver nanoparticles from Insect wing extract : Biosynthesis and evaluation for antioxidant and antimicrobial potential.

Authors’ response: Agreed. Now the title has been revised as Silver nanoparticles from Insect wing extract : Biosynthesis and evaluation for antioxidant and antimicrobial potential

4) Abstract

Results of antioxidant and antimicrobial activity need to be mentioned

Authors’ response: Results of antioxidant and antimicrobial activity are now included in abstract

Introduction

5) Need details various source of biosynthesis of NPs and antioxidant and antimicrobial properties of AgNPs

Authors’ response: Now included in MS

6) Materials and Methods

Characterization of ------

Brief details of each method should be added

Authors’ response: brief details of characterization of nanoparticles of insect wing extract by using various methods is now added in Materials and Methods under characterization of

7) Statistical analysis

Cite some reference and source of software

Authors’ response: Reference number 17 and 18 are now added and source of software i.e. IBM Corp. 2012 Statistics and Origin Pro 2015 and mentioned under subheading Statistical analysis.

Now references are cited and included

6) Results and Discussion

Figure 4a and 5a and 5b can be given as supplementary figures

R: Necessary corrections are made and given as supplementary figures

7) References

More recent and relevant references can be added

R: Now recent and relevant references added in the MS

Reviewer #3:

This is in reference to the manuscript entitled “Insect wing extract: A novel source for green synthesis of nanoparticles of antioxidant and antimicrobial potential (PONE-D-20-32626) submitted for publication in PLOS ONE journal.

The authors have presented an interesting study concerning green synthesis of nanoparticles. The topic has a novel approach. This is a very valid and interesting study, which can contribute to the body of knowledge. The paper is well-organized. The writing was sufficiently informative to deliver the message of the manuscript. A praiseworthy study was performed by the authors giving sufficient information on producing silver nanoparticles from insect wings.

Hence, I would suggest accepting the paper with minor corrections.

Mention the importance of some significant results obtained in the study in the conclusion section with an emphasis on its future applications.

Authors’ response: Importance of significant results obtained in the study and their possible future applications are now mentioned in the conclusion section.

Attachment

Submitted filename: Response to Reviewers comments.doc

Decision Letter 1

Pradeep Kumar

18 Jan 2021

Silver nanoparticles from Insect wing extract : Biosynthesis and evaluation for antioxidant and antimicrobial potential

PONE-D-20-32626R1

Dear Dr. Bee,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Pradeep Kumar

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Authors,

Thank you very much for revision of your paper. I've check the content of this paper and it was improved precisely. I have no further comments for evaluation. The manuscript is now ready for publication.

Reviewer #2: Dear Authors

The manuscript is been improved and the authors have addressed all comments given by the reviewers and editors.

Regards

Reviewer #3: The authors have well addressed all the comments. Hence, the article should be considered for publication.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Hassan Rasouli

Reviewer #2: No

Reviewer #3: No

Acceptance letter

Pradeep Kumar

16 Feb 2021

PONE-D-20-32626R1

Silver nanoparticles from Insect wing extract : Biosynthesis and evaluation for antioxidant and antimicrobial potential

Dear Dr. Hameeda:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Pradeep Kumar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Stability of MMAgNPs.

    (DOC)

    S2 Fig. Energy dispersive X-ray analysis of the synthesized MMAgNPs.

    (DOC)

    S3 Fig

    (a) Characterization of MMAgNPs by DLS size distribution. (b) Characterization of MMAgNPs by zeta potential analysis.

    (DOC)

    S4 Fig

    (a) Antibacterial activity of MMAgNPs. (b) Antifungal activity of MMAgNPs.

    (DOC)

    S1 File

    (PDF)

    S2 File

    (PDF)

    S1 Raw Image. Gel image for Fig 6.

    (TIF)

    Attachment

    Submitted filename: Response to Reviewers comments.doc

    Data Availability Statement

    All relevant data are within the manuscript file and supplementary file.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES